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involvement of these ephrin members on the catabolic/anabolic
activities of human OA chondrocytes. More speciﬁcally, we looked
at the expression level and production of EphB4 receptor and
ephrin B2, the activation of EphB4 receptor by ephrin B2 on the
modulation of cartilage catabolic/anabolic mediators in the pres-
ence/absence of IL-1β, as well as the intra-cellular signaling path-
ways employed following EphB4 receptor activation. We further
investigated factors that could modulate these ephrin members on
OA chondrocytes.
Methods: EphB4 receptor and ephrin B2 expression levels and
modulation were analyzed by quantitative-PCR and their produc-
tion by immunohistochemistry. The functional consequences of the
ephrin B2-mediated EphB4 receptor activation were investigated
by determining the production of some factors involved in the OA
process, including IL-1β, IL-6, MMP-1, MMP-2, MMP-9, MMP-13,
collagen type II and the receptor PAR-2.
Results: The EphB4 receptor and ephrin B2 ligand are expressed
by human normal and OA chondrocytes. Ephrin B2 is produced
at similar levels and localized at the superﬁcial zones in both
normal and OA cartilage. In contrast, although in normal cartilage
the EphB4 receptor is also only localized at the superﬁcial zone,
during OA it is observed throughout the cartilage layers with
signiﬁcant (p<0.01) increase in both the superﬁcial and deep
zones. This coincides with a signiﬁcant increase in EphB4 receptor
gene expression level in OA compared to normal (p<0.0001).
Modulation experiments performed on OA chondrocytes showed
that the receptor is inhibited by IL-1β and TNF-α. Interestingly,
EphB4 activation signiﬁcantly inhibited the gene expression levels
of IL-1β, IL-6, MMP-1, MMP-9, MMP-13 and PAR-2, whereas
MMP-2 was unaffected. It signiﬁcantly increased collagen type II
α1 expression and also inhibited the IL-1β-stimulated effect on the
protein production of IL-6, MMP-1 and MMP-13. EphB4 receptor
activation signiﬁcantly reduced the PI3K/Akt pathway.
Conclusions: Our study is the ﬁrst to show the presence and role
of ephrin B2/EphB4 receptor in human OA chondrocytes. The data
support the notion that activation of the EphB4 receptor by ephrin
B2 positively impacts the abnormal metabolism of OA cartilage by
inhibiting important catabolic factors involved in this disease and
at the same time as increasing the anabolic activity. Thus, ephrin
B2 could act as a speciﬁc therapeutic approach in OA by acting
both on cartilage and subchondral bone.
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Purpose: Osteoarthritis (OA) is the most common human joint
disease. Recent studies suggest the involvement of osteoprote-
gerin (OPG), receptor activator of nuclear factor-κB (RANK) and
RANK ligand (RANKL) in the abnormal OA subchondral bone
metabolism; however, very few studies have looked at these fac-
tors in the articular chondrocytes or their functional consequences
on these cells. We investigated the expression of OPG, RANK and
RANKL on human chondrocytes comparing normal to OA, and the
modulation of their production by some catabolic factors. Further,
we evaluated on human OA chondrocytes the roles of OPG and
RANKL on the production of catabolic/anabolic factors involved in
this disease.
Methods: Gene expression level was determined using real-time
PCR. The protein production of RANK and RANKL were deter-
mined by ﬂow cytometry, and that of OPG by a speciﬁc ELISA.
Modulation of OPG, RANK and RANKL was determined upon
treatment with IL-1β, TNF-α, and PGE2. The functional conse-
quences were examined following treatment with either soluble
RANKL or OPG-Fc (OPG without the heparin binding domain) at
50 and 100 ng/ml, and the production of catabolic factors including
cytokines, MMPs and PAR-2, and the anabolic factor collagen type
II evaluated.
Results: OPG, RANK and RANKL were all expressed and pro-
duced by human chondrocytes. Interestingly, data showed that
membranous RANK was produced only by an OA chondrocyte
subpopulation (29%) which was localized throughout the carti-
lage. Compared to normal, the OPG/RANKL ratio was signiﬁ-
cantly (p=0.05) reduced on the OA chondrocytes, whereas the
RANK/RANKL ratio was signiﬁcantly (p<0.03) increased. Treat-
ment with catabolic factors showed that OPG production and
membranous RANKL levels were signiﬁcantly enhanced by IL-1β,
TNF-α, and PGE2, whereas membranous RANK was signiﬁcantly
increased only with IL-1β. Administration of soluble RANKL was
without effect on the OA chondrocytes. However, addition of OPG-
Fc signiﬁcantly stimulated MMP-13 (p=0.05) and PAR-2 (p<0.04)
production.
Conclusions: Our ﬁndings showed that human normal and OA
chondrocytes express and produce OPG, RANK, and RANKL.
OA chondrocyte treatment with catabolic factors had variable
effects on each member of the triad, but pointed to an increased
biological effect of OPG. Interestingly, OPG, but not RANK or
RANKL, appears to be involved in the progression of OA by
signiﬁcantly increasing two catabolic factors involved in cartilage
pathophysiology, MMP-13 and PAR-2.
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Purpose: Pitx1 is an essential transcription factor for development
and maintenance of bone and cartilage speciﬁcally in hindlimbs
and mandible. Knockout of Pitx1 gene in mouse led to a sever
abnormalities in morphogenesis of bone and cartilage tissues
whereas Pitx1+/- mice progressively developed with ageing de-
generative changes of the knee resembling human OA. These
observations prompted us to investigate the role of this tran-
scription factor in OA patients. We have discovered that Pitx1
mRNA and proteins were hardly expressed in human OA articular
chondrocytes and cartilage sections when compared to matched
control subjects. Recent results from our lab have also shown loss
of Pitx1 expression in osteoarthritic (OA) chondrocytes. To under-
stand the mechanism that leads to loss of Pitx1 expression in OA
chondrocytes we have investigated the transcriptional regulation
of this transcription factor in normal and OA chondrocytes.
Methods: Human Pitx1 promoter gene was cloned upstream of
a luciferase reporter gene. Using C28/I2 chondrocyte cell line,
we have identiﬁed important regions for Pitx1 gene regulation
using different complementary approaches (sequencing, mass
spectrometry, DNA pull-downs method, ChIP assay and transient
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transfections). These results were also validated using primary
human OA chondrocytes.
Results: Sequencing of a 10kb fragment upstream of human
Pitx1 promoter allowed us to identify a SNP in a potential E2F
respond element located in -3900/-3800 region of Pitx1 gene
promoter. However, no association was found after validation of
this SNP in a larger OA patient cohort (n=150). Nevertheless,
using a 30bp probe, corresponding to the response element,
and a DNA pull-down approach followed by mass spectrometry
analysis (MS/MS), we discovered Prohibitin (PHB1) as the protein
that interact with this response element. We conﬁrmed this result
with DNA pull-down followed by a Western blot against PHB1
and by chromatin immunoprecipitation (ChIP) assay. We have
also found that in human OA chondrocytes, PHB1 is mostly
accumulated in nucleus whereas in control subject it is mostly
localized in cytoplasm. Overexpression of PHB1 in chondrocytes
clearly demonstrated that PHB1 represses Pitx1 at mRNA and
protein level. We also conﬁrmed this repression using a gene
reporter approach and point out that PHB1 use the -3900/-3800
response element discovered serendipitously. It has been shown
that PHB1 represses the genes that are normally regulated by
E2Fs transcription factor. Using a Luciferase reporter gene assay,
we demonstrated that E2F1 is a transcriptional activator of Pitx1
gene and PHB1 over-expression block E2F1 effect on Pitx1 gene
expression.
Conclusions: In healthy subjects, Pitx1 is normally regulated by
E2F1, but in OA condition, accumulation of PHB1 in chondrocyte
nucleus leads to Pitx1 gene repression. Further work will be
undertaken to determine the mechanism that lead to nuclear
PHB1 accumulation in OA chondrocytes.
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THE PROTECTIVE ROLE OF THE PERICELLULAR MATRIX
IN CHONDROCYTE APOPTOSIS
H.C. Peters, Z. Zhang
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Purpose: In articular cartilage, pericellular matrix (PCM) plays a
crucial role in homeostasis of chondrocytes. Apoptosis of chondro-
cytes contributes to common arthropathy such as osteoarthritis.
This study attempted to quantify the protective role of the PCM
in chondrocyte apoptosis using chondrons, which are a cartilage
functional unit including a chondrocyte and its pericellular matrix.
Methods: Chondrocytes and chondrons were enzymatically iso-
lated from human articular cartilage and exposed to monoiodoac-
etate (MIA) and staurosporine for apoptosis induction. To identify
chondrons, a basic component of the PCM, type VI collagen, was
ﬂuorescently labeled. Apoptosis of chondrocytes and chondrons
was examined using ﬂow cytometry and microscopy. Apoptosis
and cell death were separately calculated in chondrons, the type
VI collagen positive cell population, and chondrocytes.
Results: Chondrocytes treated with MIA incurred a 26.97% in-
crease in overall cell death compared to only 11.79% in chon-
drons. Chondrocytes treated with MIA underwent a 9.06% in-
crease in apoptotic cells compared to only 1.64% in chondrons.
Similarly, chondrocytes treated with staurosporine underwent a
13.64% increase in apoptotic cells while it was a 3.22% increase in
chondrons. TUNEL staining revealed that apoptotic chondrocytes
often were the core of cell aggregates, while apoptotic chondrons
did not attract cell aggregation. Caspase3 was expressed in both
stressed chondrocytes and chondrons.
Conclusions: The PCM, a native microenvironment of chondro-
cytes, plays a protective role in chondrocyte survival. Retention
of the PCM with chondrocytes is critically important in situations
such as cartilage repair and tissue engineering, which depend on
the survival of chondrocytes.
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Purpose: Organosulfur compounds such as sulforaphane and
allicin occur naturally in plants and are part of the normal diet.
Sulforaphane can inhibit tumourigenesis in animal models, has
anti-inﬂammatory properties and of particular interest, is reported
to inhibit histone deacetylase activity (Myzack et al; 2004). Allicin,
the pungent compound found in garlic, and related allyl sulfur
compounds have been shown to inhibit the proliferation of several
human tumour cell lines but not normal cells. These compounds
have been shown to modify DNA methylation and acetylation (Lea
et al; 2002). Histone deacetylase inhibitors are potential chon-
droprotective agents (Young et al; 2005, Xu et al; 2006). The aims
of this project are to test the relative efﬁcacy of dietary organosulfur
compounds as HDAC inhibitors in human chondrocytes
and to test the ability of such compounds to inhibit cartilage
resorption in a bovine nasal cartilage explant model.
Methods: Sulforaphane (SFN) and diallyl disulﬁde (DADS) were
tested for their relative efﬁcacy in modulating cytokine-induced
metalloproteinase expression and histone acetylation in chondro-
cytes using quantitative RT-PCR and Western blotting. Further-
more, these compounds were tested for their ability to prevent
cartilage destruction in the bovine nasal cartilage assay. Lactate
dehydrogenase assays were used to test for toxicity.
Results: Both SFN (5-10μM) and DADS (4-32μM) signiﬁcantly at-
tenuated IL-1β/oncostatin M-induced MMP1, MMP3, MMP13, and
ADAMTS4 expression in SW1353 chondrosarcoma cells. MMP2
and MMP28 were not affected. Basal ADAMTS5 expression was
repressed by SFN at 5-15μM. Global and histone H3 acetylation
was not affected by SFN or DADS treatment in the SW1353 cell
line. Cytokine-induced cartilage destruction was abrogated in a
dose dependent manner by SFN (5-30μM) and DADS (8-32μM),
measured by collagen and glycosaminoglycan release.
Conclusions: Type II collagen and aggrecan are major struc-
tural components of cartilage. MMP-1 and MMP-13 are key col-
lagenolytic metalloproteinases in arthritic disease since they can
degrade collagen type II. ADAMTS-4 and ADAMTS-5 have ag-
grecanase activity. SFN and DADS can attenuate the induction of
these genes in a dose dependent manner but do not appear to
function through the inhibition of histone deacetylases. SFN and
DADS are potential chondroprotective agents.
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PHOSPHATE AND CALCIUM INFLUX ARE REQUIRED FOR
TGFβ-MEDIATED STIMULATION OF ANK (progressive
ankylosis) EXPRESSION AND PPi TRANSPORT FUNCTION
DURING CHONDROGENESIS
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Purpose: Genetic studies of familial chondrocalcinosis and cranial
metaphyseal dysplasia have identiﬁed ANK, a multipass trans-
membrane protein, as a key player in biomineralization. The ex-
pression of ANK is stimulated by treatment of a variety of cell types
with growth factors, including TGFβ. The purpose of this study was
to determine whether TGFβ stimulation of ANK expression and
function during chondrogenesis was dependent upon the inﬂux of
calcium and phosphate into the cells.
Methods: ATDC5 cells were differentiated from immaturity through
hypertrophy with and without the addition of TGFβ1. Inhibitors of
TGFβ signaling were used to identify the signaling pathway em-
